Kairos Pharma Ltd. Gains 51.05%

Tue, Nov 12, 2024 at 07:33 PM

Kairos Pharma Ltd. (KAPA:NYSEMKT) soared at $2.05, a gain of 51.1%. On Tue, Nov 12, 2024, KAPA:NYSEMKT hit a New 2-Week High of $2.05. The stock got featured on our News Catalysts scanner on Tue, Oct 22, 2024 at 10:28 AM in the 'MISCELLANEOUS' category. From Wed, Oct 30, 2024, the stock recorded 55.56% Up Days and 40.00% Green Days

About Kairos Pharma Ltd. (KAPA:NYSEMKT)

Kairos Pharma is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance.

Top 10 Gainers:

BTC Digital Ltd. (BTCT:NASDAQ), 316.67%
Nano Labs Ltd (NA:NASDAQ), 134.04%
Next Technology Holding Inc. (NXTT:NASDAQ), 76.52%
Mullen Automotive Inc. (MULN:NASDAQ), 74.27%
Genius Group Limited (GNS:NYSEMKT), 66.4%
Agrify Corporation (AGFY:NASDAQ), 58.59%
Genprex, Inc. (GNPX:NASDAQ), 55.97%
Kairos Pharma Ltd. (KAPA:NYSEMKT), 51.05%
MediciNova, Inc. (MNOV:NASDAQ), 49.02%
Taysha Gene Therapies Inc. (TSHA:NASDAQ), 46.63%